Medtox Scientific, Inc. (MTOX) Misses Q4 EPS by 1c, Sales Top Just Slightly

Medtox Scientific, Inc. (NASDAQ: MTOX) reported Q4 EPS of $0.11, $0.01 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $26.9 million versus the consensus estimate of $26.88 million.

For earnings history and earnings-related data on Medtox Scientific, Inc. (MTOX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• QT Imaging reports 116% revenue jump in first half of 2026
• Enhanced Group plans AI health platform launch in 2026